Back to trial details

Intake questionnaire

DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers

Applying to University of Kentucky Medical Center · Lexington, Kentucky

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Small Cell Lung Cancer?
3. Are you able to travel to Lexington for study visits?